What’s new in heart failure? An update from Professor Carolyn Lam
Heart Podcast
00:00
Is Women Underrepresented in Heart Failure Trials?
Women continue to be underrepresented in our heart failure trials. A sex neutral cut off of 50% could already be reduced for women, whereas it's still normal for men. Women appear to benefit from sacubitrivial sartan across a larger ejection fractions range compared to men.
Transcript
Play full episode
